Related Experiment Videos
Psoriasis clinical registries, genetics, and genomics
1Departments of Dermatology and Radiation Oncology (Cancer Biology), University of Michigan, Ann Arbor Veterans Affairs Hospital, MI 3312, USA. jelder@umich.edu
Annals of the Rheumatic Diseases
|February 15, 2005
Summary
Genomic studies and new psoriasis therapies can work together. This review examines psoriasis registries for genetic research, comparing data needs and patient privacy concerns.
Area of Science:
- Dermatology and genetics, focusing on psoriasis and psoriatic arthritis.
Background:
- Genetics and genomics are increasingly used to understand psoriasis.
- Numerous biological therapies are advancing, leading to more patient participation in clinical trials.
- Synergistic opportunities exist between clinical trials and genetic/genomic research in psoriasis.
Purpose of the Study:
- Review existing psoriasis clinical registries, particularly those used for genetic studies.
- Compare and contrast data requirements for genetic, genomic, and clinical registries.
- Evaluate the impact of patient privacy on the utilization of registries for clinical and genetic research.
Main Methods:
- Literature review of psoriasis registries and genetic studies.
- Comparative analysis of data types needed for different registry purposes.
- Discussion of ethical considerations, specifically patient privacy.
Main Results:
- Existing registries vary in their suitability for genetic and genomic research.
- Different types of registries (clinical, genetic, genomic) require distinct data points.
- Patient privacy concerns significantly influence data accessibility and usability.
Conclusions:
- Integrating clinical and genetic/genomic data from registries can accelerate psoriasis research.
- Standardizing data collection and addressing privacy are crucial for maximizing registry utility.
- Collaboration between clinical and research efforts is essential for advancing psoriasis understanding and treatment.